StockData
NewcelX Ltd. logo

NewcelX Ltd. (NCEL) stock

NCELNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 29, 2026Score 4/30
$2.54−0.15 (-5.58%)

Close on Nov 20, 2026Market cap $12.19MP/E 1.2Yield –

NewcelX ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

For fiscal 2025 it was -$2.51M.

Annual ebitda

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$2.51M–
FY2024Dec 31, 2024-$1.65M–
FY2023Dec 31, 2023-$2.40M–

More NewcelX figures

See a number that looks wrong?